NO/GMP as mediators of estrogen effects in bone
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
BMC pharmacology & toxicology - 16(2015), Suppl 1 vom: 02. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kalyanaraman, Hema [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| BKL: | |
|---|---|
| Themen: |
Guanylate Cyclase |
| Anmerkungen: |
© Kalyanaraman and Joshua et al. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( |
|---|
| doi: |
10.1186/2050-6511-16-S1-A10 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2095024354 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2095024354 | ||
| 003 | DE-627 | ||
| 005 | 20240408161724.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230331s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/2050-6511-16-S1-A10 |2 doi | |
| 035 | |a (DE-627)OLC2095024354 | ||
| 035 | |a (DE-He213)2050-6511-16-S1-A10-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 44.38 |2 bkl | ||
| 100 | 1 | |a Kalyanaraman, Hema |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a NO/GMP as mediators of estrogen effects in bone |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Kalyanaraman and Joshua et al. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( | ||
| 650 | 4 | |a Osteoporosis | |
| 650 | 4 | |a Guanylate Cyclase | |
| 650 | 4 | |a Increase Breast Cancer Risk | |
| 650 | 4 | |a Soluble Guanylate Cyclase | |
| 650 | 4 | |a Ovariectomized Mouse | |
| 700 | 1 | |a Joshua, Jisha |4 aut | |
| 700 | 1 | |a Zhuang, Shunhui |4 aut | |
| 700 | 1 | |a Corey, Esther |4 aut | |
| 700 | 1 | |a Sah, Robert |4 aut | |
| 700 | 1 | |a Pilz, Renate B |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC pharmacology & toxicology |d BioMed Central, 2012 |g 16(2015), Suppl 1 vom: 02. Sept. |h Online-Ressource |w (DE-627)723899754 |w (DE-600)2680259-4 |w (DE-576)370708180 |x 2050-6511 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2015 |g number:Suppl 1 |g day:02 |g month:09 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/2050-6511-16-S1-A10 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-DE-84 | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_170 | ||
| 912 | |a GBV_ILN_206 | ||
| 912 | |a GBV_ILN_213 | ||
| 912 | |a GBV_ILN_230 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_2446 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4322 | ||
| 912 | |a GBV_ILN_4323 | ||
| 912 | |a GBV_ILN_4324 | ||
| 912 | |a GBV_ILN_4325 | ||
| 912 | |a GBV_ILN_4338 | ||
| 912 | |a GBV_ILN_4367 | ||
| 912 | |a GBV_ILN_4700 | ||
| 936 | b | k | |a 44.38 |j Pharmakologie |j Pharmakologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 16 |j 2015 |e Suppl 1 |b 02 |c 09 | ||